Skip to main content

Articles

Page 10 of 20

  1. Harm reduction refers to interventions aimed at reducing the negative effects of health behaviors without necessarily extinguishing the problematic health behaviors completely. The vast majority of the harm re...

    Authors: Mary Hawk, Robert W. S. Coulter, James E. Egan, Stuart Fisk, M. Reuel Friedman, Monique Tula and Suzanne Kinsky
    Citation: Harm Reduction Journal 2017 14:70
  2. People who inject drugs (PWID) take on significant risks of contracting blood-borne infection, including injecting with a large number of partners and acquiring needles from unsafe sources. When combined, risk...

    Authors: Ian Duncan, Patrick Habecker, Roberto Abadie, Ric Curtis, Bilal Khan and Kirk Dombrowski
    Citation: Harm Reduction Journal 2017 14:69
  3. As postsecondary students’ use of “study drugs” becomes more popular with increasingly reported negative effects on health and academic performance, failing prohibitionist policies to reduce consumption, and a...

    Authors: Dor David Abelman
    Citation: Harm Reduction Journal 2017 14:68
  4. Although opioid-dependent patients are disproportionately impacted by hepatitis C (HCV), many do not receive treatment. In addition to HCV treatment-access barriers, substance-using patients may be reluctant t...

    Authors: A. W. Batchelder, L. Cockerham-Colas, D. Peyser, S. P. Reynoso, I. Soloway and A. H. Litwin
    Citation: Harm Reduction Journal 2017 14:67
  5. In Hong Kong, methadone maintenance treatment (MMT) was launched in the 1970s, almost 30 years before the counterpart programme’s inauguration in Mainland China. Both were established in response to perceived ...

    Authors: Shui-Shan Lee and Robert Newman
    Citation: Harm Reduction Journal 2017 14:66
  6. Pharmacies are an important source of sterile syringes for people who inject drugs (PWID) in Tajikistan who are under high risk of HIV and hepatitis C virus. Accessibility of sterile syringes at pharmacies wit...

    Authors: Umedjon Ibragimov, Hannah L. Cooper, Regine Haardörfer, Kristin L. Dunkle, William A. Zule and Frank Y. Wong
    Citation: Harm Reduction Journal 2017 14:64
  7. Methadone maintenance therapy (MMT) is a mainstay for treating opioid use disorder and preventing and managing HIV among people who inject drugs (PWID). While previous research suggested low dosing of methadon...

    Authors: Kanna Hayashi, Lianping Ti, Prempreeda Pramoj Na Ayutthaya, Paisan Suwannawong, Karyn Kaplan, Will Small and Thomas Kerr
    Citation: Harm Reduction Journal 2017 14:63
  8. Persons who use opioids have a high risk of overdose and associated mortality. In Vietnam, little is known about the characteristics of this population and the persons who are witness to those overdoses. One a...

    Authors: N.A. Blackburn, K.E. Lancaster, T.V. Ha, C.A. Latkin, W.C. Miller, C. Frangakis, V.A. Chu, T. Sripaipan, V.M. Quan, N.L. Minh, P.T. Vu and V.F. Go
    Citation: Harm Reduction Journal 2017 14:62
  9. In December 2016, the Surgeon General published a report that concluded e-cigarette use among youth and young adults is becoming a major public health concern in the United States of America.

    Authors: Riccardo Polosa, Christopher Russell, Joel Nitzkin and Konstantinos E. Farsalinos
    Citation: Harm Reduction Journal 2017 14:61
  10. Treatment resistant cluster headache and migraine patients are exploring alternative treatments online. The aim of this study was to improve comprehension regarding the use of non-established or alternative ph...

    Authors: Martin Andersson, Mari Persson and Anette Kjellgren
    Citation: Harm Reduction Journal 2017 14:60
  11. Vietnam began providing methadone maintenance therapy (MMT) in 2008; as of June 2016, 44,479 persons who inject drugs (PWID) were in treatment in 57 provinces. However, 10–23% of patients were estimated to hav...

    Authors: Pham Minh Khue, Nguyen Thi Tham, Dinh Thi Thanh Mai, Pham Van Thuc, Vu Minh Thuc, Pham Van Han and Christina Lindan
    Citation: Harm Reduction Journal 2017 14:59
  12. People who inject drugs (PWID) frequently engage in injection risk behaviours exposing them to blood-borne infections. Understanding the underlying causes that drive various types and levels of risk behaviours...

    Authors: Niklas Karlsson, Michele Santacatterina, Kerstin Käll, Maria Hägerstrand, Susanne Wallin, Torsten Berglund and Anna Mia Ekström
    Citation: Harm Reduction Journal 2017 14:57
  13. Patients with substance use disorders grow older thanks to effective treatments. Together with a high prevalence of comorbidities, psychological problems, and low social support, these patients are at high ris...

    Authors: Samuel S. Allemann, Kenneth M. Dürsteler, Johannes Strasser, Marc Vogel, Marcel Stoeckle, Kurt E. Hersberger and Isabelle Arnet
    Citation: Harm Reduction Journal 2017 14:56
  14. Studies on contraceptive use by patients with substance use disorders (SUD) show a concerning low use of contraception. Mainly conducted in USA, they could be irrelevant to patients attending European SUD trea...

    Authors: Virgile Clergue-Duval, Suzanne Robin, Maeva Fortias, Gaël Dupuy, Béatrice Badin-de-Montjoye and Florence Vorspan
    Citation: Harm Reduction Journal 2017 14:54
  15. Youth substance use programming and educational strategies are frequently informed by prevention approaches that emphasize abstinence goals, which often do not resonate with youth in their lack of acknowledgme...

    Authors: Emily K. Jenkins, Allie Slemon and Rebecca J. Haines-Saah
    Citation: Harm Reduction Journal 2017 14:53
  16. In Canada, funding, administration, and delivery of health services—including those targeting people who use drugs—are primarily the responsibility of the provinces and territories. Access to harm reduction se...

    Authors: Elaine Hyshka, Jalene Anderson-Baron, Kamagaju Karekezi, Lynne Belle-Isle, Richard Elliott, Bernie Pauly, Carol Strike, Mark Asbridge, Colleen Dell, Keely McBride, Andrew Hathaway and T. Cameron Wild
    Citation: Harm Reduction Journal 2017 14:50
  17. Gambling has quickly emerged as an important global public health issue. With new technologies used to develop high intensity gambling products and promotions aimed at driving consumption, public health organi...

    Authors: Samantha L. Thomas, Melanie Randle, Amy Bestman, Hannah Pitt, Steven J. Bowe, Sean Cowlishaw and Mike Daube
    Citation: Harm Reduction Journal 2017 14:49
  18. There is good evidence to suggest that performance and image enhancing drug (PIED) use is increasing in Australia and that there is an increase in those using PIEDs who have never used another illicit substanc...

    Authors: Boden Tighe, Matthew Dunn, Fiona H. McKay and Timothy Piatkowski
    Citation: Harm Reduction Journal 2017 14:48
  19. The Golden Crescent region of South Asia—comprising Afghanistan, Iran, and Pakistan—is a principal global site for opium production and distribution. Over the past few decades, war, terrorism, and a shifting p...

    Authors: Syeda Ayesha Farooq, Mohammad Hafiz Rasooly, Syed Hani Abidi, Kayvon Modjarrad and Syed Ali
    Citation: Harm Reduction Journal 2017 14:47
  20. Supervised injection services (SIS) have been shown to reduce the public- and individual-level harms associated with injection drug use. While SIS feasibility research has been conducted in large urban centres...

    Authors: Sanjana Mitra, Beth Rachlis, Ayden Scheim, Geoff Bardwell, Sean B. Rourke and Thomas Kerr
    Citation: Harm Reduction Journal 2017 14:46
  21. In 2015, the Australian government launched the media campaign Ice Destroys Lives targeting crystal methamphetamine use. Previous research indicates mass media campaigns may have harmful effects for people engage...

    Authors: Caitlin H. Douglass, Elizabeth C. Early, Cassandra J. C. Wright, Anna Palmer, Peter Higgs, Brendan Quinn, Paul M. Dietze and Megan S. C. Lim
    Citation: Harm Reduction Journal 2017 14:45
  22. New, more effective and better-tolerated therapies for hepatitis C (HCV) have made the elimination of HCV a feasible objective. However, for this to be achieved, it is necessary to have a detailed understandin...

    Authors: Ryan Buchanan, Salim I. Khakoo, Jonathan Coad, Leonie Grellier and Julie Parkes
    Citation: Harm Reduction Journal 2017 14:44
  23. Kyrgyzstan, where HIV is concentrated in prisons and driven by injection drug use, provides a prison-based methadone maintenance therapy program as well as abstinence-oriented therapeutic community based on th...

    Authors: Lyuba Azbel, Julia Rozanova, Ingo Michels, Frederick L. Altice and Heino Stöver
    Citation: Harm Reduction Journal 2017 14:43
  24. Authors: Claire E. Kendall, Lisa M. Boucher, Amy E. Mark, Alana Martin, Zack Marshall, Rob Boyd, Pam Oickle, Nicola Diliso, Dave Pineau, Brad Renaud, Tiffany Rose, Sean LeBlanc, Mark Tyndall, Olivia M. Lee and Ahmed M. Bayoumi
    Citation: Harm Reduction Journal 2017 14:42

    The original article was published in Harm Reduction Journal 2017 14:16

  25. Personal networks are significant social spaces to spread of HIV or other blood-borne infections among hard-to-reach population, viz., injecting drug users, female sex workers, etc. Sharing of infected needles...

    Authors: Sanjib Kumar Phukan, Gajendra Kumar Medhi, Jagadish Mahanta, Rajatashuvra Adhikary, Gay Thongamba, Ramesh S. Paranjape and Brogen S. Akoijam
    Citation: Harm Reduction Journal 2017 14:41
  26. Women who inject drugs (WWID) are at heightened risk for HIV due to biological, behavioral, and structural factors. Pre-exposure prophylaxis (PrEP) could aid in HIV prevention for WWID. However, little is know...

    Authors: Suzan M. Walters, Kathleen H. Reilly, Alan Neaigus and Sarah Braunstein
    Citation: Harm Reduction Journal 2017 14:40
  27. Harm reduction interventions in Cambodia face numerous obstacles because of conflicting understanding and interests and inconsistencies in the implementation by law enforcement officials. This study aims to ex...

    Authors: Sovannary Tuot, Chanrith Ngin, Khuondyla Pal, Sochenda Sou, Ghazal Sawez, Phylicia Morgan, Mony Srey, Tola Chan, Pheak Chhoun, Olga Golichenko, Sok Chamreun Choub and Siyan Yi
    Citation: Harm Reduction Journal 2017 14:39
  28. WHO, UNODC, and UNAIDS recommend a comprehensive package for prevention, treatment, and care of HIV among people who inject drugs (PWID). We describe the uptake of services and the cost of implementing a compr...

    Authors: Mary Philip Sebastian, Aparajita Dasgupta, Lopamudra Ray Saraswati, Asha Singh, Vartika Sharma, Ira Madan, Waimar Tun, Julie Pulerwitz, Ibou Thior and Avina Sarna
    Citation: Harm Reduction Journal 2017 14:38
  29. Stigma, criminalisation and a lack of data on drug use contribute to the “invisibility” of people who inject drugs (PWID) and make HIV prevention and treatment service delivery challenging. We aimed to confirm...

    Authors: Andrew Scheibe, Shaun Shelly, Andrew Lambert, Andrea Schneider, Rudolf Basson, Nelson Medeiros, Kalvanya Padayachee, Helen Savva and Harry Hausler
    Citation: Harm Reduction Journal 2017 14:35
  30. Take home naloxone (THN) programs reduce mortality by training bystanders to respond to opioid overdoses. Clinical observation by the health care team at the Inner City Youth (ICY) program indicated that young...

    Authors: Keren Mitchell, S. Elise Durante, Katrina Pellatt, Chris G. Richardson, Steve Mathias and Jane A. Buxton
    Citation: Harm Reduction Journal 2017 14:34
  31. The HIV epidemic among people who inject drugs (PWID) in Russia continues to spread. This exploratory study examines how HIV-prevention measures are perceived and experienced by PWID in the northwestern region...

    Authors: Peter Meylakhs, Aadne Aasland and Arne Grønningsæter
    Citation: Harm Reduction Journal 2017 14:33
  32. Injection drug use is associated with HIV and hepatitis C transmission, overdose, and other preventable harms. These harms are heightened for structurally vulnerable injection drug-using populations, as their ...

    Authors: Jade Boyd, Danya Fast, Megan Hobbins, Ryan McNeil and Will Small
    Citation: Harm Reduction Journal 2017 14:31
  33. Housing First is an evidence-based practice intended to serve chronically homeless individuals with co-occurring serious mental illness and substance use disorders. Despite housing active substance users, harm...

    Authors: Dennis P. Watson, Valery Shuman, James Kowalsky, Elizabeth Golembiewski and Molly Brown
    Citation: Harm Reduction Journal 2017 14:30
  34. Canada has long contended with harms arising from injection drug use. In response to epidemics of HIV infection and overdose in Vancouver in the mid-1990s, a range of actors advocated for the creation of super...

    Authors: Thomas Kerr, Sanjana Mitra, Mary Clare Kennedy and Ryan McNeil
    Citation: Harm Reduction Journal 2017 14:28
  35. This article highlights the experiences of a peer-run group, SALOME/NAOMI Association of Patients (SNAP), that meets weekly in the Downtown Eastside of Vancouver, British Columbia, Canada. SNAP is a unique ind...

    Authors: Susan Boyd, Dave Murray and Donald MacPherson
    Citation: Harm Reduction Journal 2017 14:27

    The Erratum to this article has been published in Harm Reduction Journal 2017 14:36

  36. Little is known about access to health insurance among people who inject drugs (PWID) who attend syringe exchange programs (SEPs). The goal of the current study was to assess perceptions of SEP staff, includin...

    Authors: Thomas J. Stopka, Marguerite Hutcheson and Ashley Donahue
    Citation: Harm Reduction Journal 2017 14:26
  37. Previous research on the effectiveness of needle exchange programs (NEP) in preventing hepatitis C virus (HCV) in people who inject drugs (PWID) has shown mixed findings. The purpose of this study was to use t...

    Authors: Stephen M. Davis, Shay Daily, Alfgeir L. Kristjansson, George A. Kelley, Keith Zullig, Adam Baus, Danielle Davidov and Melanie Fisher
    Citation: Harm Reduction Journal 2017 14:25
  38. Syringe sharing is a high-risk practice associated with the transmission of infectious diseases, such as HIV and HCV. While youth who contend with housing instability are known to be more likely to engage in h...

    Authors: Andreas Pilarinos, Mary Clare Kennedy, Ryan McNeil, Huiru Dong, Thomas Kerr and Kora DeBeck
    Citation: Harm Reduction Journal 2017 14:24
  39. The majority of Americans with opioid use disorder remain out of treatment. Operating in 33 states, Washington DC, and Puerto Rico, harm reduction agencies, which provide sterile syringes and other health serv...

    Authors: Aaron D. Fox, Nancy L. Sohler, Taeko Frost, Carolina Lopez and Chinazo O. Cunningham
    Citation: Harm Reduction Journal 2017 14:23
  40. The perspectives of people who use drugs are critical in understanding why people choose to reduce harm in relation to drug use, what practices are considered or preferred in conceptualizations of harm reducti...

    Authors: L. M. Boucher, Z. Marshall, A. Martin, K. Larose-Hébert, J. V. Flynn, C. Lalonde, D. Pineau, J. Bigelow, T. Rose, R. Chase, R. Boyd, M. Tyndall and C. Kendall
    Citation: Harm Reduction Journal 2017 14:18